Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA lifts hold on Cellectis’ CAR-T trial, adds go-slow caveat

fiercebiotechNovember 08, 2017

Tag: FDA , Cellectis , CAR-T

PharmaSources Customer Service